Home / Specialties / Cardiology / Bruce Neal ADA 2017 Pt.5, FDA SGLT2 Guidelines

Bruce Neal ADA 2017 Pt.5, FDA SGLT2 Guidelines

Diabetes In Control Publisher Steve Freed speaks with CANVAS study lead author, Bruce Neal, MB, ChB, PhD, of the George Institute for Global Health at UNSW Sydney, who presented the findings at the 77th Scientific Sessions of the American Diabetes Association’s in San Diego, California.

In Part 5 of this exclusive interview, Dr. Neal discusses whether current prescribing guidelines for canagliflozen need updating.

Featured videos include:

Pt.1: CANVAS Program and Cardiovascular Event Reduction

Pt.2: CANVAS Program and Renal Protection

Pt.3: CANVAS Program Compared to Other Studies

Pt.4: CANVAS Program, What Should be Taken Away

Pt.5: FDA SGLT2 Guidelines

Pt.6: Adverse Effects for SGLT2

or view the complete interview here: Complete Interview